NCT00400322View on ClinicalTrials.gov

Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Glioblastoma MultiformeCytomegalovirus Infection
Interventions
DRUG

Valganciclovir (Valcyte)

OTHER

Placebo

Trial Locations (3)

17176

Department of neurosurgery, Karolinska University Hospital, Solna

901 85

Department of Oncology, Norrland University Hospital, Umeå

751 85

Department of Oncology, Akademiska Hospital, Uppsala

All Listed Sponsors
collaborator

Karolinska University Hospital

OTHER

lead

Karolinska Institutet

OTHER

NCT00400322 - Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection | Biotech Hunter | Biotech Hunter